Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.6 INR | -0.60% |
|
-0.72% | -11.21% |
06-05 | Cop Life Science Limited Announces Launch of New Product, CROPLOD | CI |
06-05 | Crop Life Science Limited Launches New Product, FRONTONI | CI |
Income Statement Evolution (Annual data)
Fiscal Period: February | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 1,351 | 1,189 | 1,020 | 1,337 |
EBITDA 1 | 79.06 | 85.34 | 73.09 | 115.4 |
EBIT 1 | 65.16 | 63.78 | 54.84 | 92.59 |
Operating Margin | 4.82% | 5.36% | 5.38% | 6.93% |
Earnings before Tax (EBT) 1 | 45.88 | 49.25 | 37.69 | 66.35 |
Net income 1 | 32.3 | 37.05 | 28.14 | 47.64 |
Net margin | 2.39% | 3.11% | 2.76% | 3.56% |
EPS 2 | 2.690 | 3.087 | 2.345 | 3.970 |
Free Cash Flow | - | -15.49 | -70.85 | - |
FCF margin | - | -1.3% | -6.95% | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 5/15/23 | 5/15/23 | 5/15/23 | 8/14/23 |
Balance Sheet Analysis
Fiscal Period: February | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 137 | 152 | 195 | 259 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 1.735 x | 1.775 x | 2.662 x | 2.245 x |
Free Cash Flow | - | -15.5 | -70.9 | - |
ROE (net income / shareholders' equity) | - | 11.8% | 8.14% | - |
ROA (Net income/ Total Assets) | - | 4.9% | 3.79% | - |
Assets 1 | - | 756.3 | 742.6 | - |
Book Value Per Share 2 | 24.80 | 27.60 | 30.00 | 33.70 |
Cash Flow per Share 2 | 1.920 | 2.570 | 1.720 | 1.140 |
Capex 1 | 7.54 | 26.3 | 43.7 | 54 |
Capex / Sales | 0.56% | 2.21% | 4.28% | 4.04% |
Announcement Date | 5/15/23 | 5/15/23 | 5/15/23 | 8/14/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-11.21% | 8.54M | |
+6.80% | 35.67B | |
-.--% | 11.49B | |
-13.10% | 6.84B | |
+3.62% | 6.61B | |
-3.21% | 6.04B | |
-9.30% | 5.86B | |
-11.47% | 5.24B | |
+28.21% | 5.06B | |
-6.02% | 4.96B |
- Stock Market
- Equities
- CLSL Stock
- Financials Crop Life Science Limited